These data are consistent with the hypothesis that an increase of CDK5R1 expression, and consequent enhanced CDK5 activity, caused by downregulation of the miR-15/107 family has a role in the pathogenesis of AD. The gene discussed is CDK5; the disease is Alzheimer disease.